Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed,
and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government
operating status and resumption of normal operations can be found at opm.gov.
The primary objective of this study is to determine whether rosuvastatin reduces the combined endpoint of cardiovascular death or non-fatal myocardial infarction (MI) or non-fatal stroke (time to first event).
The secondary objectives are to evaluate the effects of rosuvastatin on:
(and 3 more...)
60 Years and older (Adult, Senior)
4522IL/0098 D3562C00098 CORONA
September 21, 2005
November 19, 2010
Research Site Aalst, Belgium
Research Site Bouge, Belgium
Research Site Brugge, Belgium
(and 375 more...)
† Study has passed its completion date and status has not been verified in more than two years.